CS
EVH icon

Candriam SCA’s Evolent Health EVH Stock Holding History

Candriam SCA’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-185,228
Closed -$6.07M – 699
2024
Q1 		$6.07M Buy
185,228
+6,565
+4% +$209K 0.04% 308
2023
Q4 		$5.9M Buy
+178,663
New +$5.06M 0.04% 320

Other funds holding EVH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Candriam SCA's EVH Position: Q2 2024 in Review

Candriam SCA sold out of Evolent Health (EVH) in Q2 2024, closing a stake of 185,228 shares — an estimated $6.07M sold.

Candriam SCA first reported a position in EVH in Q4 2023 and held it in 2 quarters. The position peaked at $6.07M in Q1 2024. 243 funds tracked by Wall St. Rank hold EVH as of Q2 2024.

  • Candriam SCA reported no remaining Evolent Health position as of Q2 2024 after selling out during the quarter.
  • Candriam SCA sold 185,228 Evolent Health shares in Q2 2024, an estimated $6.07M.
  • Candriam SCA first reported a position in Evolent Health in Q4 2023 and held it in 2 quarters.
  • Candriam SCA's Evolent Health position peaked at $6.07M in Q1 2024.
  • 243 funds tracked by Wall St. Rank held Evolent Health as of Q2 2024.

Based on Candriam SCA's 13F filing for Q2 2024, filed 5 Aug 2024.